Hims & Hers Health ROE 2020-2025 | HIMS

Current and historical return on equity (ROE) values for Hims & Hers Health (HIMS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Hims & Hers Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.16B $0.55B 35.89%
2024-12-31 $0.13B $0.48B 31.05%
2024-09-30 $0.10B $0.44B 27.11%
2024-06-30 $0.02B $0.36B 4.93%
2024-03-31 $0.00B $0.34B -0.90%
2023-12-31 $-0.02B $0.34B -7.35%
2023-09-30 $-0.04B $0.33B -11.30%
2023-06-30 $-0.05B $0.32B -14.97%
2023-03-31 $-0.06B $0.31B -19.12%
2022-12-31 $-0.07B $0.31B -20.79%
2022-09-30 $-0.09B $0.31B -26.60%
2022-06-30 $-0.08B $0.32B -24.83%
2022-03-31 $-0.07B $0.33B -21.97%
2021-12-31 $-0.11B $0.34B -33.57%
2021-09-30 $-0.08B $0.36B -40.86%
2021-06-30 $-0.07B $0.29B -64.11%
2021-03-31 $-0.06B $0.29B -162.58%
2020-12-31 $-0.02B $-0.15B 54.55%
2020-06-30 $-0.01B $0.01B -186.67%
2020-03-31 $-0.01B $0.01B -240.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.418B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.172B 58.74
Tempus AI (TEM) United States $12.340B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $3.751B 58.61
Privia Health (PRVA) United States $2.761B 188.75
Hinge Health (HNGE) United States $2.719B 0.00
Enovis (ENOV) United States $1.822B 10.16
Schrodinger (SDGR) United States $1.572B 0.00
Phreesia (PHR) United States $1.547B 0.00
Clover Health Investments (CLOV) United States $1.468B 0.00
Azenta (AZTA) United States $1.401B 65.11
Omnicell (OMCL) United States $1.370B 24.17
10x Genomics (TXG) United States $1.282B 0.00
Fulgent Genetics (FLGT) United States $0.630B 0.00
Claritev (CTEV) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.477B 142.50
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.347B 769.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
Pulmonx (LUNG) United States $0.122B 0.00
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.095B 0.00
CareCloud (CCLD) United States $0.088B 3.34
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00